ISRCTN24534559已完成不适用

COMbining Plasmafiltration and Adsorption Clinical Trial: efficacy and safety of coupled plasma filtration adsorption for septic shock in the intensive care unit - an open-label randomised controlled multi-centre trial

Italian Group for the Evaluation of Interventions in Intensive Care Medicine (GiViTI)0 个研究点目标入组 330 人开始时间: 2006年7月11日最近更新: 2015年1月13日

适应症

试验速览

暂无简介。

•All patients admitted to the ICU in septic shock or that develop septic shock while in the IC

•Patients with any of the following characteristics::
•1. Age less than 18 years
•2. Pregnancy
•3. Cardiopulmonary resuscitation
•4. Cerebral coma (Glasgow coma score [GCS] <8 due to organic cerebral diseases, irrespective of their surgical, non-surgical, or trauma origin)
•5. Metastatic cancer
•6. Presence of relative or absolute contraindications to CPFA
•7. Estimated life expectancy less than two weeks
•8. Already included in the study
•9. Admission from another ICU where the patient has been admitted for more than 24 hours
•10. Absence of informed consent

发起方

Italian Group for the Evaluation of Interventions in Intensive Care Medicine (GiViTI)